BrainStorm Has Secured a Second Manufacturing Facility for NurOwn, an Experimental Drug for ALS

BrainStorm Cell Therapeutics Inc. has announced that it has secured its second U.S. manufacturing location for NurOwn®, an experimental drug currently under investigation for the treatment of amyotrophic lateral sclerosis…

Continue Reading BrainStorm Has Secured a Second Manufacturing Facility for NurOwn, an Experimental Drug for ALS
This Company Announced That it Won’t Provide Its Experimental Treatment for Amyotrophic Lateral Sclerosis Under Right to Try
Source: Pixabay

This Company Announced That it Won’t Provide Its Experimental Treatment for Amyotrophic Lateral Sclerosis Under Right to Try

According to a story from reuters.com, the U.S.-Israeli company BrainStorm Therapeutics will not provide its investigational stem cell treatment under the recently passed U.S. Right to Try law. The company…

Continue Reading This Company Announced That it Won’t Provide Its Experimental Treatment for Amyotrophic Lateral Sclerosis Under Right to Try
Phase II Trial for Investigational Gaucher Disease Drug Begins
Source: Pixabay

Phase II Trial for Investigational Gaucher Disease Drug Begins

According to a story from GlobeNewsWire, the biopharmaceutical company Orphazyme A/S, which is committed to the development of treatments for patients that are living with rare diseases, has recently announced…

Continue Reading Phase II Trial for Investigational Gaucher Disease Drug Begins
An Experimental Drug for ALS Patients Will Become Available Through an Expanded Access Program
Source: Pixabay

An Experimental Drug for ALS Patients Will Become Available Through an Expanded Access Program

The pharmaceutical company Biohaven has announced that they will be using an expanded access program to make an experimental drug for amyotrophic lateral sclerosis (ALS) available to patients before F.D.A.…

Continue Reading An Experimental Drug for ALS Patients Will Become Available Through an Expanded Access Program
Recent Surveys Show What Patients Really Think About Their Standard of Care
Source: Pixabay

Recent Surveys Show What Patients Really Think About Their Standard of Care

An organisation called PatientsLikeMe that helps to represent patients to governments and pharmaceutical companies has published a press release about the results of two recent studies designed to define and…

Continue Reading Recent Surveys Show What Patients Really Think About Their Standard of Care
Exposure to Diesel Exhaust Could Increase the Risk of Amyotrophic Lateral Sclerosis, Study Says
Source: Pixabay

Exposure to Diesel Exhaust Could Increase the Risk of Amyotrophic Lateral Sclerosis, Study Says

According to a story from webmd.com, diesel exhaust could increase the risk of developing amyotrophic lateral sclerosis, also known as Lou Gehrig disease. People who are exposed to diesel exhaust…

Continue Reading Exposure to Diesel Exhaust Could Increase the Risk of Amyotrophic Lateral Sclerosis, Study Says
A Drug That Can Mimic Exercise May Be Closer Than You Thought
Source: Pixabay

A Drug That Can Mimic Exercise May Be Closer Than You Thought

Scientists in California at Salk Institute for Biological Studies are currently developing a drug that can mimic the effects in the body usually obtained from exercise, reports the National Post.…

Continue Reading A Drug That Can Mimic Exercise May Be Closer Than You Thought
Researchers Close to Medical Breakthroughs Concerning  Amyotrophic Lateral Sclerosis and Muscular Dystrophy
Source: Pixabay

Researchers Close to Medical Breakthroughs Concerning Amyotrophic Lateral Sclerosis and Muscular Dystrophy

Originally reported by Columbia Daily Tribune, researchers from the University of Missouri have made huge strides towards treating, and maybe even curing, two fatal diseases: muscular dystrophy and Amyotrophic Lateral…

Continue Reading Researchers Close to Medical Breakthroughs Concerning Amyotrophic Lateral Sclerosis and Muscular Dystrophy
AveXis, Gene Therapy Development Company, Expands Program
Source: Pixabay

AveXis, Gene Therapy Development Company, Expands Program

The gene therapy development company, AveXis, Incorporation, just announced that they will be expanding their clinical trial development program for the potential gene therapy treatment: AVXS-101, reported Globe News Wire.…

Continue Reading AveXis, Gene Therapy Development Company, Expands Program
Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients
Pexels / Pixabay

Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients

According an article from CityNews Toronto, an anti-psychotic medication is undergoing clinical trials in the treating of amyotrophic lateral sclerosis. In other studies, the treatment has shown to help slow…

Continue Reading Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients